Arterial grafts are frequently used in modern coronary artery bypass grafting (CABG) and the benefit of the 2 internal mammary arteries (IMA) has already been established. However, the choice of the third arterial conduit, in addition to the IMA, is controversial. We have retrospectively analized perioperative and the follow-up results of patients who underwent CABG with triple arterial bypass using either the radial artery (RA) or the gastroepiploic artery (GEA) in conjunction with the bilateral IMA (BIMA). Between December 1995 and June 2001, 1,516 consecutive isolated CABG operations were performed at Shin-Tokyo Hospital. Among them the RA and BIMA were used in 96 patients (78 males, 18 females; mean age, 63.2±6.7 years, group R), and the GEA and BIMA in 123 patients (101 males, 22 females; mean age, 61.0±11.6 years, group G). Their perioperative and follow-up data were studied. The preoperative risk factors were similar between the 2 groups, except that there were significantly fewer patients with renal dysfunction in group R. The surgical results did not differ between the 2 groups; however, the GEA was more commonly used for revascularization of the right coronary artery, while the RA was used for the diagonal, circumflex or right coronary arteries. Surgical mortality and morbidity rates were not significantly different. During the follow-up period of 2.3±1.6 years, the event-free rates as well as the survival rates were not significantly different. CABG with either the RA or the GEA in conjunction with the BIMA can be performed safely. The surgical results as well as the follow-up results were acceptable and no significant differences between the 2 groups were observed. (Circ J 2002; 66: 544 -548) 
o avoid remote cardiac events associated with graft occlusions, which are known to occur more frequently in saphenous vein grafts than the arterial grafts, the use of arterial conduits is increasing in coronary artery bypass grafting (CABG). In particular, the internal mammary arteries (IMAs) are the most frequently used and their patency rates have been reported to be 90% or higher even 10 years after CABG. 1, 2 Furthermore, CABG using the bilateral IMAs (BIMA) provides better event-free rates than a single IMA in selected patients. 1 However, the choice of the third arterial conduit in addition to the BIMA remains controversial. In our institute, the gastroepiploic artery (GEA) or radial artery (RA) has been utilized as the third graft of choice. We performed retrospective analysis to verify the safety and efficacy of the RA vs the GEA in conjunction with the BIMA.
Methods
Between December 1995 and June 2001, a total of 1,516 consecutive patients underwent isolated CABG at ShinTokyo Hospital Cardiovascular Group (Shin-Tokyo Hospital, Kobari General Hospital and Northern Yokohama Hospital) and of these 96 patients (6.3%) had a BIMA and RA bypass (group R), and 123 patients (8.1%) had the BIMA and GEA (group G). Those who underwent CABG with both the RA and GEA in conjunction with the BIMA were excluded (81 patients).
Patients with uncontrolled diabetes or severe osteoporosis who were considered to be at high risk for sternal complications did not undergo BIMA harvesting. RA harvest was avoided in patients with renal dysfunction or a positive Allen test. The contraindications for GEA harvest were a history of upper abdominal surgery, active peptic ulcer or the presence of a gastroduodenal mass.
After harvesting the appropriate grafts, CABG was performed under normothermia (36°C) with cardiopulmonary bypass. After September 1996, selected cases underwent off-pump CABG. 2 The RA was used for aortocoronary bypass or as a composite graft with the left IMA (LIMA), whereas the GEA was routinely used as an in-situ graft.
Postoperative angiography was performed on selected patients: the first 25 patients systematically underwent coronary angiography within 3 months of surgery, and thereafter, early coronary angiography was performed either because of the poor quality of the native coronary arteries or at the request of the referring cardiologist.
Using a retrospective chart review, we collected the following parameters: patient's age, gender, cardiac profile, preoperative risk factors, graft material, surgical data, postoperative complications and mortality. Outpatient follow-up was completed by the referring cardiologist or the hospital's outpatient clinic and the follow-up data were compiled by August 31, 2001. The endpoint was any type of death or the occurrence of a cardiac event, which included myocardial infarction, angina, arrhythmia requiring hospitalization, congestive heart failure requiring hospitalization, native coronary artery or graft stenosis requiring any type of coronary intervention and sudden death.
Results were expressed as mean ± standard deviation. Statistical analyses were performed using the Student's ttests or Mann-Whitney's U-tests as appropriate for continuous variables, or the chi-square tests (Fisher's exact tests if n<5) for categorical variables. A p-value less than 0.05 was considered significant. The survival and event-free rates were calculated using the Kaplan -Meier method. All statistical analyses were performed using Statview version 5.0 (SAS Institute, Cary, NC, USA).
Results

Patients' Characteristics
Group R comprised 96 patients (78 males, 18 females; mean age, 63.2±6.7 years) and group G had 123 patients (101 males, 22 females; mean age, 61.0±11.6 years). The preoperative data are described in Table 1 . The RA was not used in patients with severe renal dysfunction. Otherwise, the other preoperative comorbidities did not significantly different between 2 groups.
Surgical Results
The surgical data are shown in Table 2 . The mean number of distal anastomoses was 3.6±0.8 in group R and 3.8±0.8 in group G (p=NS). An additional saphenous vein graft was used in 16 patients (16.7%) in group R and 25 (20.3%) in group G (p=NS).
The target vessel for each graft is shown in were often the right coronary artery (RCA). Seven patients had a relatively large GEA that was used for bypass to the circumflex artery (CX). The RA was used for the CX, RCA or diagonal artery. Aortocoronary bypass using the RA was performed in 86 patients (89.6%) and composite Y-grafts in 10 patients (10.4%). All composite Y-grafts were created with the LIMA. The operating time was longer in group G (361.5±70.3 min) than in group R (330.3±63.9 min) (p<0.001), although neither the clamp time nor the pump time were significantly different between the 2 groups. Off-pump bypass was performed in 52 patients in group R and 51 patients in group G (p=NS). The average local coronary clamp time in those who underwent off-pump CABG was 11.5±2.2 min in group R and 11.2±2.5 min in group G (p=NS).
Postoperative Course
The postoperative course is dysplayed in Table 4 . Neither the postoperative intubation time nor the postoperative stay was different between the 2 groups, although group G required a longer intensive care unit (ICU) stay than group R. No deaths occurred in either group. The major complication rates were not significantly different: 10.4% in group R and 13.7% in group G. There were 2 incidences of RA harvesting-related complications: both were wound separations requiring delayed closure. No abdominal complications were observed in either group. Perioperative myocardial infarction occurred in 2 cases, both of which were related to native artery spasm, and the grafts were patent on coronary angiography.
Follow-up Results
Postoperative follow-up was completed in all patients with a mean follow-up period of 2.3±1.6 years. During the follow-up period, cardiac events occurred in 7 patients (7.3%) in group R and 18 patients (14.6%) in group G (Table 5) . Two patients in group R and one in group G with postoperative angina underwent percutaneous transluminal coronary angioplasty (PTCA), but all other patients with angina were controlled with medication. The actuarial 1-, 2-, and 3-year event-free rates were 95.2%, 90.3%, 90.3% in group R and 94.8%, 89.2%, and 83.0% in group G, respectively, which was not significantly different by logrank tests.
During the same follow-up period, there were 1 death in group R and 7 deaths in group G, giving actuarial 1-, 2-, and 3-year survival rates of 100%, 100%, 97.3% in group R, and 99.1%, 95.8%, and 95.8% in group G, respectively (p=NS).
Angiographic Results
Angiographic control (angiography performed within 3 months of surgery) was obtained in 50 patients (52.1%) in group R and 38 patients (30.9%) in group G. There was 1 RA occlusion, but the patient remained symptom-free; thus, remained under observation alone. Stenosis occurred in 6 other RA grafts and in 4 GEA grafts, but only 1 case of stenosis in the mid-portion of a RA-RCA graft was treated with PTCA to the graft; the other patients were symptom free and followed-up medically. The early stenosis-free patency rate was 89.9% in the RA and 92.9% in the GEA, which was not significantly different.
Discussion
LIMA-left anterior descending artery (LAD) grafting provides excellent long-term patient survival and freedom from cardiac events. 3, 5 Although the use of the BIMA may increase postoperative sternal wound complications, some reports supported the superior long-term benefit of BIMA grafting compared with a single IMA grafting. 3, 5 In-situ IMA has proven better graft patency than aortocoronary bypass. 7 LIMA patency rates at 5-and 10-years were reported to be 97% and 89%, respectively. 8 In-situ right IMA (RIMA) patency rates at 1-and 5-years were 99% and 93%, respectively, and free RIMA patency rates 96% and 93%, respectively. 9 In our practice, the BIMA are usually used as in-situ grafts in one of the following combinations: LIMA-LAD and RIMA-diagonal, LIMA-LAD and RIMA-RCA, LIMA-LAD and RIMA-obtuse marginal artery, or LIMA-CX and RIMA-LAD. Prior to the use of arterial grafts, other coronary arteries were revascularized with a saphenous vein graft, but its graft patency rate was far inferior to that of IMA grafts: 75-80% at 5 years and 50-65% at 10 years. 11 In addition, saphenous vein graft disease usually appeared a few years after surgery and accelerated more than 5 years after surgery. 11 The majority of late cardiac events are associated with graft occlusions. CABG using the RA and/or the GEA was developed in the expectation of a superior graft patency than the saphenous vein graft.
The RA was first used by Carpentier et al in 1973, 9 but the initial results were poor because of early graft closure and frequent vasospasm; thus, they abandoned its use in CABG. However, in 1992, Acar et al reported good clinical results of RA grafting, using an alternative harvesting technique and modern anti-spasm agents. 10 The RA is a muscular artery, liable to vasospasm. 11 In our institute, the prophilaxis of vasospasm is achieved by systemic administration of a calcium channel blocker, such as nicorandil and/or diltiazem, and by direct infusion of diluted papaverine or milrinone into the harvested RA pedicle. A recent review of RA grafting reported an early patency rate of between 95.7% and 100%, and a mid-term patency rate of between 87.5% and 100%. 12 The longest angiographical follow-up of the RA was reported by Acar: graft patency rates of 99% early post-operation, 92% at 1 year and 83% at 5 years. 13 In the present series, there was 1 case of early RA occlusion, giving early RA patency rate of 98.6%.
The length of the harvested RA pedicle is 18-20 cm, which is enough to bypass any part of the coronary artery. To optimize graft length, we have recently harvested the RA as a skeletonized graft, using an ultrasonic scalpel. In our practice, the majority of RA grafts are used for aortocoronary bypass, which can provide sufficient graft flow to the distal coronary artery. If the length of the harvested RA graft is too short or the ascending aorta is calcified, the RA is used as a composite graft. Harvest-related complications of the RA were minimal in the present series. There was 1 case of early postoperative hematoma requiring drainage, and another case of wound infection requiring delayed closure. No patients, in this series, developed permanent sensory disturbance.
The GEA was first used by Suma et al in 1979. 14 The reported patency rate at 5 years was 92%. 15 GEA harvest requires a laparotomy, which can be performed with a small caudal extension of the midline incision (5-6 cm). There were no complications related to GEA harvesting in the present study. None of the patients developed postoperative bowel obstruction, gastrointestinal bleeding or delay of feeding. The time required for a GEA harvest is approximately 20 min, which is similar to IMA harvest. The dissection can be carried out from the mid portion of the stomach to the head of the pancreas. The length of the GEA pedicle is usually enough for bypassing the distal RCA, although a large GEA can be used to bypass the distal CX. The GEA is also a muscular artery and we use the same anti-spasm protocol as for the RA. However, in our experience, the GEA is more prone to vasospasm than the RA and its diameter is smaller than that of the RA. We therefore use the GEA only as an in-situ graft and limit the graft target to the distal RCA.
Our study demonstrated almost identical surgical results using the RA or the GEA as the third arterial graft; postoperative complications and recovery did not significantly differ, except for a slightly longer ICU stay in the GEA group, which can be attributed to relatively greater number of patients with preoperative renal dysfunction in that group. The early angiography results demonstrated that the stenosis-free rates were not significantly different between the RA and GEA grafts. The postoperative cardiac events in both groups were adequately controlled during the limited follow-up period, but the late graft patency has not been determined.
Although the perioperative risks were similar between the 2 groups, the graft selection (RA vs GEA) was not randomly assigned; our preferred choice of graft designs using the RA are LIMA-LAD, RIMA-CX, and RA-RCA, or LIMA-LAD, RIMA-RCA, and RA-CX (RA may be used as a composite graft with the LIMA if the ascending aorta is calcified), or LIMA-CX, RIMA-LAD, and RA-RCA, whereas the preferred graft designs with the GEA are LIMA-LAD, RIMA-CX, and GEA-RCA, or LIMA-CX, RIMA-LAD, and GEA-RCA. Revascularization of the RCA may be done with any one of the RIMA, RA or GEA. If the patient's aorta is calcified, an in-situ graft, such as the RIMA or GEA, should be chosen rather than aortocoronary bypass using the RA. If the RA used as an aortocoronary bypass, it can provide higher graft flow than the in-situ GEA. The RCA with mild proxymal stenosis and high distal coronary flow should not be revascularized with the GEA, but the RA. Since the surgical and early follow-up results were similar for the use of the RA or the GEA as the third graft, the selection of the third arterial graft may be depend upon the design of the grafts.
Summary
Triple arterial bypass using the BIMA and either the RA or GEA provided a good short-term outcomes within a limited follow-up period. The RA can be used to bypass a variety of coronary arteries, whereas the GEA can be used only for revascularization of the RCA because of the limited length of the in-situ graft. In-situ GEA grafting or composite RA grafting should be chosen for patients with a calcified aorta. The procedural complications and outcomes were otherwise not significantly different between the RA and the GEA. Further follow-up is necessary to determine the long-term outcomes.
